Viewing StudyNCT05257395



Ignite Creation Date: 2024-05-06 @ 5:16 PM
Last Modification Date: 2024-10-26 @ 2:26 PM
Study NCT ID: NCT05257395
Status: NOT_YET_RECRUITING
Last Update Posted: 2022-02-25
First Post: 2022-02-16

Brief Title: A Study of XZP-3287 in Combination With LetrozoleAnastrozole in Patients With Advanced Breast Cancer
Sponsor: Xuanzhu Biopharmaceutical Co Ltd
Organization: Xuanzhu Biopharmaceutical Co Ltd

Conditions & Keywords Data

Conditions:
Name
Advanced Breast Cancer
Keywords:
Name View
HR positive Her2 negative recurrentmetastatic breast cancer View
XZP-3287 View